Tvardi Therapeutics Ord Shs
TVRD4.690USD
-0.140-2.90%
終値 01/23, 16:00（ET）15分遅れの株価
43.99M時価総額
損失額直近12ヶ月PER
詳細情報 企業名
Tvardi Therapeutics Ord Shsの企業情報
企業コード- -
会社名- -
上場日- -
最高経営責任者「CEO」- -
従業員数- -
証券種類- -
決算期末- -
本社所在地- -
都市- -
証券取引所- -
国- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コード- -
上場日- -
最高経営責任者「CEO」- -
Tvardi Therapeutics Ord Shsの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
Mr. Dan Conn, J.D.
Mr. Dan Conn, J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. John Kauh, M.D.
Dr. John Kauh, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jeffrey (Jeff) Larson, Ph.D.
Dr. Jeffrey (Jeff) Larson, Ph.D.
Senior Vice President - Research & Development
Senior Vice President - Research & Development
--
--
Dr. Yixin (Joseph) Chen, Ph.D.
Dr. Yixin (Joseph) Chen, Ph.D.
Vice President - Chemistry, Manufacturing and Controls
Vice President - Chemistry, Manufacturing and Controls
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace Hall
Mr. Wallace Hall
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Tue, Dec 9
通貨: USD更新時刻: Tue, Dec 9
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q3
FY2023Q2
FY2023Q1
FY2021
事業別USD
会社名
収益
比率
Other revenue
1.32M
51.50%
Collaborative revenue
1.20M
46.63%
Clinical compound revenue
48.00K
1.87%
Commercial supply revenue
0.00
0.00%
地域別USD
会社名
収益
比率
United States
0.00
0.00%
事業別
地域別
事業別USD
会社名
収益
比率
Other revenue
1.32M
51.50%
Collaborative revenue
1.20M
46.63%
Clinical compound revenue
48.00K
1.87%
Commercial supply revenue
0.00
0.00%
株主
更新時刻: Wed, Dec 10
更新時刻: Wed, Dec 10
株主統計
種類
株主統計
株主統計
比率
Sporos Bioventures LLC
8.93%
Solas Tvardi Sidecar LLC
8.11%
Slate Path Capital LP
7.51%
Tweardy (David John)
6.92%
DePinho (Ronald A)
6.67%
他の
61.86%
株主統計
株主統計
比率
Sporos Bioventures LLC
8.93%
Solas Tvardi Sidecar LLC
8.11%
Slate Path Capital LP
7.51%
Tweardy (David John)
6.92%
DePinho (Ronald A)
6.67%
他の
61.86%
種類
株主統計
比率
Corporation
19.23%
Individual Investor
17.56%
Hedge Fund
11.09%
Investment Advisor
11.02%
Investment Advisor/Hedge Fund
5.38%
Research Firm
0.51%
Bank and Trust
0.09%
Pension Fund
0.08%
Insurance Company
0.02%
他の
35.02%
機関投資家保有株
更新時刻: Wed, Jan 21
更新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
126
2.64M
22.11%
--
2025Q4
201
2.64M
28.19%
+318.90K
2025Q3
240
2.63M
28.09%
+211.56K
2025Q2
255
1.96M
20.86%
+381.35K
2025Q1
304
216.78K
14.22%
-690.19K
2024Q4
335
370.98K
24.35%
-475.57K
2024Q3
349
383.52K
25.18%
-554.07K
2024Q2
363
500.51K
32.96%
-507.31K
2024Q1
376
666.56K
43.91%
-330.38K
2023Q4
385
694.09K
45.87%
-306.90K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Sporos Bioventures LLC
837.64K
8.93%
--
--
Oct 20, 2025
Solas Tvardi Sidecar LLC
761.29K
8.11%
--
--
Oct 20, 2025
Slate Path Capital LP
704.12K
7.51%
--
--
Sep 30, 2025
Tweardy (David John)
649.05K
6.92%
--
--
Oct 20, 2025
DePinho (Ronald A)
626.19K
6.67%
-151.45K
-19.48%
Sep 30, 2025
The Vanguard Group, Inc.
419.17K
4.47%
+20.76K
+5.21%
Sep 30, 2025
Tweardy (Samuel David)
315.66K
3.36%
-631.32K
-66.67%
Jul 07, 2025
BlackRock Institutional Trust Company, N.A.
305.94K
3.26%
+58.48K
+23.63%
Sep 30, 2025
Vifor (International), Ltd
205.47K
2.19%
-1.00
-0.00%
Apr 16, 2025
683 Capital Management LLC
176.03K
1.88%
--
--
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Tue, Dec 9
更新時刻: Tue, Dec 9
銘柄名
比率
Invesco Dorsey Wright SmallCap Momentum ETF
0.04%
Texas Capital Texas Small Cap Equity Index ETF
0.01%
iShares Russell 2000 ETF
0%
Fidelity Enhanced Small Cap ETF
0%
iShares Russell 2000 Growth ETF
0%
Amplify Seymour Cannabis ETF
0%
iShares Russell 3000 ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
ProShares UltraPro Russell2000
0%
詳細を見る
Invesco Dorsey Wright SmallCap Momentum ETF
比率0.04%
Texas Capital Texas Small Cap Equity Index ETF
比率0.01%
iShares Russell 2000 ETF
比率0%
Fidelity Enhanced Small Cap ETF
比率0%
iShares Russell 2000 Growth ETF
比率0%
Amplify Seymour Cannabis ETF
比率0%
iShares Russell 3000 ETF
比率0%
Global X Russell 2000 ETF
比率0%
Schwab U.S. Small-Cap ETF
比率0%
ProShares UltraPro Russell2000
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
Apr 14, 2025
Merger
3→1
日付
配当落ち日
種類
比率
Apr 14, 2025
Merger
3→1
